Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BA.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used